vs
EverCommerce Inc.（EVCM）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是EverCommerce Inc.的1.5倍（$219.9M vs $151.2M），EverCommerce Inc.净利率更高（4.0% vs -1.0%，领先5.0%），EverCommerce Inc.同比增速更快（5.2% vs 2.0%），EverCommerce Inc.自由现金流更多（$21.0M vs $16.8M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs 4.7%）
EverCommerce Inc.是面向服务类中小企业的领先集成SaaS解决方案提供商，核心市场覆盖北美及部分全球区域，产品线包含业务管理、支付处理、客户互动、营销工具等，服务家庭服务、健康康养、健身等多个细分领域。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
EVCM vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.5倍
$151.2M
营收增速更快
EVCM
高出3.2%
2.0%
净利率更高
EVCM
高出5.0%
-1.0%
自由现金流更多
EVCM
多$4.2M
$16.8M
两年增速更快
OFIX
近两年复合增速
4.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $151.2M | $219.9M |
| 净利润 | $6.0M | $-2.2M |
| 毛利率 | — | 71.1% |
| 营业利润率 | 8.8% | 0.2% |
| 净利率 | 4.0% | -1.0% |
| 营收同比 | 5.2% | 2.0% |
| 净利润同比 | 149.4% | 92.4% |
| 每股收益（稀释后） | $0.04 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EVCMOFIX
| Q4 25 | $151.2M | $219.9M | ||
| Q3 25 | $147.5M | $205.6M | ||
| Q2 25 | $148.0M | $203.1M | ||
| Q1 25 | $142.3M | $193.6M | ||
| Q4 24 | $143.7M | $215.7M | ||
| Q3 24 | $140.1M | $196.6M | ||
| Q2 24 | $140.5M | $198.6M | ||
| Q1 24 | $137.9M | $188.6M |
净利润EVCMOFIX
| Q4 25 | $6.0M | $-2.2M | ||
| Q3 25 | $11.1M | $-22.8M | ||
| Q2 25 | $8.2M | $-14.1M | ||
| Q1 25 | $-7.7M | $-53.1M | ||
| Q4 24 | $-12.2M | $-29.1M | ||
| Q3 24 | $-9.2M | $-27.4M | ||
| Q2 24 | $-3.4M | $-33.4M | ||
| Q1 24 | $-16.3M | $-36.0M |
毛利率EVCMOFIX
| Q4 25 | — | 71.1% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 68.7% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | — | 68.7% | ||
| Q2 24 | — | 67.8% | ||
| Q1 24 | — | 67.5% |
营业利润率EVCMOFIX
| Q4 25 | 8.8% | 0.2% | ||
| Q3 25 | 10.8% | -8.3% | ||
| Q2 25 | 10.7% | -7.9% | ||
| Q1 25 | 10.0% | -25.2% | ||
| Q4 24 | 8.8% | -5.3% | ||
| Q3 24 | 7.2% | -9.6% | ||
| Q2 24 | 5.5% | -12.5% | ||
| Q1 24 | -3.1% | -15.6% |
净利率EVCMOFIX
| Q4 25 | 4.0% | -1.0% | ||
| Q3 25 | 7.5% | -11.1% | ||
| Q2 25 | 5.5% | -6.9% | ||
| Q1 25 | -5.4% | -27.4% | ||
| Q4 24 | -8.5% | -13.5% | ||
| Q3 24 | -6.5% | -13.9% | ||
| Q2 24 | -2.4% | -16.8% | ||
| Q1 24 | -11.8% | -19.1% |
每股收益（稀释后）EVCMOFIX
| Q4 25 | $0.04 | $-0.05 | ||
| Q3 25 | $0.06 | $-0.57 | ||
| Q2 25 | $0.04 | $-0.36 | ||
| Q1 25 | $-0.04 | $-1.35 | ||
| Q4 24 | $-0.06 | $-0.76 | ||
| Q3 24 | $-0.05 | $-0.71 | ||
| Q2 24 | $-0.02 | $-0.88 | ||
| Q1 24 | $-0.09 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.7M | $82.0M |
| 总债务越低越好 | $523.4M | — |
| 股东权益账面价值 | $716.9M | $450.0M |
| 总资产 | $1.4B | $850.6M |
| 负债/权益比越低杠杆越低 | 0.73× | — |
8季度趋势，按日历期对齐
现金及短期投资EVCMOFIX
| Q4 25 | $129.7M | $82.0M | ||
| Q3 25 | $106.9M | $62.9M | ||
| Q2 25 | $151.1M | $65.6M | ||
| Q1 25 | $148.4M | $58.0M | ||
| Q4 24 | $135.8M | $83.2M | ||
| Q3 24 | $101.6M | $30.1M | ||
| Q2 24 | $86.7M | $26.4M | ||
| Q1 24 | $90.0M | $27.0M |
总债务EVCMOFIX
| Q4 25 | $523.4M | — | ||
| Q3 25 | $524.6M | $157.2M | ||
| Q2 25 | $525.8M | $157.0M | ||
| Q1 25 | $526.9M | $156.9M | ||
| Q4 24 | $527.9M | $157.0M | ||
| Q3 24 | $529.0M | $118.5M | ||
| Q2 24 | $530.1M | $118.0M | ||
| Q1 24 | $531.1M | $118.2M |
股东权益EVCMOFIX
| Q4 25 | $716.9M | $450.0M | ||
| Q3 25 | $728.5M | $442.5M | ||
| Q2 25 | $744.0M | $458.3M | ||
| Q1 25 | $739.6M | $458.3M | ||
| Q4 24 | $750.8M | $503.1M | ||
| Q3 24 | $770.7M | $525.9M | ||
| Q2 24 | $784.1M | $546.0M | ||
| Q1 24 | $800.7M | $570.3M |
总资产EVCMOFIX
| Q4 25 | $1.4B | $850.6M | ||
| Q3 25 | $1.4B | $832.6M | ||
| Q2 25 | $1.4B | $837.2M | ||
| Q1 25 | $1.4B | $823.1M | ||
| Q4 24 | $1.4B | $893.3M | ||
| Q3 24 | $1.5B | $867.9M | ||
| Q2 24 | $1.5B | $882.0M | ||
| Q1 24 | $1.5B | $906.0M |
负债/权益比EVCMOFIX
| Q4 25 | 0.73× | — | ||
| Q3 25 | 0.72× | 0.36× | ||
| Q2 25 | 0.71× | 0.34× | ||
| Q1 25 | 0.71× | 0.34× | ||
| Q4 24 | 0.70× | 0.31× | ||
| Q3 24 | 0.69× | 0.23× | ||
| Q2 24 | 0.68× | 0.22× | ||
| Q1 24 | 0.66× | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.3M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $21.0M | $16.8M |
| 自由现金流率自由现金流/营收 | 13.9% | 7.6% |
| 资本支出强度资本支出/营收 | 0.2% | 4.9% |
| 现金转化率经营现金流/净利润 | 3.52× | — |
| 过去12个月自由现金流最近4个季度 | $109.2M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流EVCMOFIX
| Q4 25 | $21.3M | $27.7M | ||
| Q3 25 | $32.5M | $12.4M | ||
| Q2 25 | $27.0M | $11.6M | ||
| Q1 25 | $30.7M | $-18.4M | ||
| Q4 24 | $48.4M | $23.7M | ||
| Q3 24 | $27.5M | $11.7M | ||
| Q2 24 | $23.9M | $9.0M | ||
| Q1 24 | $13.3M | $-18.6M |
自由现金流EVCMOFIX
| Q4 25 | $21.0M | $16.8M | ||
| Q3 25 | $31.6M | $2.5M | ||
| Q2 25 | $26.5M | $4.5M | ||
| Q1 25 | $30.2M | $-25.1M | ||
| Q4 24 | $48.2M | $15.2M | ||
| Q3 24 | $27.4M | $6.3M | ||
| Q2 24 | $23.3M | $-360.0K | ||
| Q1 24 | $12.9M | $-29.1M |
自由现金流率EVCMOFIX
| Q4 25 | 13.9% | 7.6% | ||
| Q3 25 | 21.4% | 1.2% | ||
| Q2 25 | 17.9% | 2.2% | ||
| Q1 25 | 21.2% | -13.0% | ||
| Q4 24 | 33.5% | 7.0% | ||
| Q3 24 | 19.5% | 3.2% | ||
| Q2 24 | 16.6% | -0.2% | ||
| Q1 24 | 9.4% | -15.4% |
资本支出强度EVCMOFIX
| Q4 25 | 0.2% | 4.9% | ||
| Q3 25 | 0.6% | 4.8% | ||
| Q2 25 | 0.3% | 3.5% | ||
| Q1 25 | 0.3% | 3.5% | ||
| Q4 24 | 0.2% | 4.0% | ||
| Q3 24 | 0.1% | 2.7% | ||
| Q2 24 | 0.5% | 4.7% | ||
| Q1 24 | 0.3% | 5.6% |
现金转化率EVCMOFIX
| Q4 25 | 3.52× | — | ||
| Q3 25 | 2.93× | — | ||
| Q2 25 | 3.31× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EVCM
| Transferred Over Time | $146.4M | 97% |
| Transferred At Point In Time | $4.8M | 3% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
